Phase 2 DLBCL - Diffuse Large B Cell Lymphoma Clinical Trials
12 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–12 of 12 trials
Recruiting
Phase 2
CAR-T Followed by Bispecific Antibodies
DLBCL - Diffuse Large B Cell LymphomaLarge B-cell Lymphoma
Abramson Cancer Center at Penn Medicine23 enrolled2 locationsNCT04889716
Recruiting
Phase 1Phase 2
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
DLBCL - Diffuse Large B Cell LymphomaLymphomaLymphoplasmacytic Lymphoma+5 more
ModeX Therapeutics, An OPKO Health Company180 enrolled2 locationsNCT07249905
Recruiting
Phase 2
Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
Diffuse Large B Cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma
Virginia Commonwealth University21 enrolled1 locationNCT06846463
Recruiting
Phase 2
DALY II Japan/MB-CART2019.1 for DLBCL
DLBCL - Diffuse Large B Cell LymphomaCAR-T Cell Therapy
Miltenyi Biomedicine GmbH31 enrolled5 locationsNCT07288879
Recruiting
Phase 2
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaStage III High Grade B-Cell Lymphoma+7 more
Memorial Sloan Kettering Cancer Center50 enrolled7 locationsNCT06736613
Recruiting
Phase 2
Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL
DLBCL - Diffuse Large B Cell Lymphoma
The First Affiliated Hospital of Soochow University29 enrolled1 locationNCT07255963
Recruiting
Phase 2
Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes
DLBCL - Diffuse Large B Cell LymphomaChidamideR-CHOP Chemotherapy+1 more
The First Affiliated Hospital with Nanjing Medical University148 enrolled1 locationNCT06891157
Recruiting
Phase 2
AZA Combined With RCHOP in P53-mutated DLBCL.
DLBCL - Diffuse Large B Cell LymphomaTP53
The First Affiliated Hospital of Xiamen University52 enrolled1 locationNCT06158399
Recruiting
Phase 2
Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma
The First Affiliated Hospital of Xiamen University38 enrolled1 locationNCT06151080
Recruiting
Phase 2
Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL
DLBCL - Diffuse Large B Cell LymphomaNHL
University Medical Center Groningen300 enrolled7 locationsNCT05641428
Recruiting
Phase 2
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
Colorectal, CancerSquamous Cell Carcinoma of Head and NeckDLBCL - Diffuse Large B Cell Lymphoma+4 more
Zhejiang Provincial People's Hospital260 enrolled1 locationNCT06534762
Recruiting
Phase 2
Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL
High-grade B-cell LymphomaDLBCL - Diffuse Large B Cell LymphomaHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements+4 more
Australasian Leukaemia and Lymphoma Group39 enrolled1 locationNCT06287398